TY - JOUR
T1 - HIP fracture Supplemental Therapy to Enhance Recovery (HIPSTER)
T2 - a protocol for a randomised controlled trial
AU - Kimmel, Lara A.
AU - Raper, Eleanor
AU - Harris, Ian A.
AU - Ackerman, Ilana N.
AU - Page, Richard
AU - Naylor, Justine M.
AU - Burge, Angela T.
AU - Hepworth, Graham
AU - Harris, Anthony
AU - Woode, Maame Esi
AU - Gabbe, Belinda J.
AU - Ekegren, Christina L.
AU - Holland, Anne E.
N1 - Funding Information:
This work was supported by the Medical Research Future Fund grant number 000166. This funding source had no role in the design of this study and will not have any role during its execution, analysis, interpretation of the data or decision to submit results. AEH is supported by National Health and Medical Council (Australia) Investigator Grant GNT1197007. BJG is supported by the National Health and Medical Council (Australia) Investigator Grant 2009998.
Publisher Copyright:
© 2023 Annals of the Rheumatic Diseases. All rights reserved.
PY - 2024/1
Y1 - 2024/1
N2 - Introduction Hip fractures result in substantial health impacts for patients and costs to health systems. Many patients require prolonged hospital stays and up to 60% do not regain their prefracture level of mobility within 1 year. Physical rehabilitation plays a key role in regaining physical function and independence; however, there are no recommendations regarding the optimal intensity. This study aims to compare the clinical efficacy and cost-effectiveness of early intensive in-hospital physiotherapy compared with usual care in patients who have had surgery following a hip fracture. Methods and analysis This two-arm randomised, controlled, assessor-blinded trial will recruit 620 participants who have had surgery following a hip fracture from eight hospitals. Participants will be randomised 1:1 to receive usual care (physiotherapy according to usual practice at the site) or intensive physiotherapy in the hospital over the first 7 days following surgery (two additional sessions per day, one delivered by a physiotherapist and the other by an allied health assistant). The primary outcome is the total hospital length of stay, measured from the date of hospital admission to the date of hospital discharge, including both acute and subacute hospital days. Secondary outcomes are functional mobility, health-related quality of life, concerns about falling, discharge destination, proportion of patients remaining in hospital at 30 days, return to preadmission mobility and residence at 120 days and adverse events. Twelve months of follow-up will capture data on healthcare utilisation. A cost-effectiveness evaluation will be undertaken, and a process evaluation will document barriers and facilitators to implementation. Ethics and dissemination The Alfred Hospital Ethics Committee has approved this protocol. The trial findings will be published in peer-reviewed journals, submitted for presentation at conferences and disseminated to patients and carers. Trial registration number ACTRN12622001442796.
AB - Introduction Hip fractures result in substantial health impacts for patients and costs to health systems. Many patients require prolonged hospital stays and up to 60% do not regain their prefracture level of mobility within 1 year. Physical rehabilitation plays a key role in regaining physical function and independence; however, there are no recommendations regarding the optimal intensity. This study aims to compare the clinical efficacy and cost-effectiveness of early intensive in-hospital physiotherapy compared with usual care in patients who have had surgery following a hip fracture. Methods and analysis This two-arm randomised, controlled, assessor-blinded trial will recruit 620 participants who have had surgery following a hip fracture from eight hospitals. Participants will be randomised 1:1 to receive usual care (physiotherapy according to usual practice at the site) or intensive physiotherapy in the hospital over the first 7 days following surgery (two additional sessions per day, one delivered by a physiotherapist and the other by an allied health assistant). The primary outcome is the total hospital length of stay, measured from the date of hospital admission to the date of hospital discharge, including both acute and subacute hospital days. Secondary outcomes are functional mobility, health-related quality of life, concerns about falling, discharge destination, proportion of patients remaining in hospital at 30 days, return to preadmission mobility and residence at 120 days and adverse events. Twelve months of follow-up will capture data on healthcare utilisation. A cost-effectiveness evaluation will be undertaken, and a process evaluation will document barriers and facilitators to implementation. Ethics and dissemination The Alfred Hospital Ethics Committee has approved this protocol. The trial findings will be published in peer-reviewed journals, submitted for presentation at conferences and disseminated to patients and carers. Trial registration number ACTRN12622001442796.
KW - aged
KW - aged, 80 and over
KW - hip
KW - hospitalization
KW - physical therapy modalities
KW - rehabilitation medicine
UR - http://www.scopus.com/inward/record.url?scp=85182854533&partnerID=8YFLogxK
U2 - 10.1136/bmjopen-2023-079846
DO - 10.1136/bmjopen-2023-079846
M3 - Article
C2 - 38238172
AN - SCOPUS:85182854533
SN - 2044-6055
VL - 14
JO - BMJ Open
JF - BMJ Open
IS - 1
M1 - e079846
ER -